chr12-80341991-T-C

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_001378609.3(OTOGL):​c.5094T>C​(p.Asn1698Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.61 in 1,605,588 control chromosomes in the GnomAD database, including 306,149 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.52 ( 22649 hom., cov: 32)
Exomes 𝑓: 0.62 ( 283500 hom. )

Consequence

OTOGL
NM_001378609.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.263

Publications

20 publications found
Variant links:
Genes affected
OTOGL (HGNC:26901): (otogelin like) The protein encoded by this gene belongs to the otogelin family. This gene is expressed in the inner ear of vertebrates with the highest level of expression seen at the embryonic stage and lowest in adult. Knockdown studies in zebrafish suggest that this gene is essential for normal inner ear function. Mutations in this gene are associated with autosomal recessive deafness. [provided by RefSeq, Dec 2012]
OTOGL Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 84B
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.032).
BP6
Variant 12-80341991-T-C is Benign according to our data. Variant chr12-80341991-T-C is described in ClinVar as [Benign]. Clinvar id is 226952.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.263 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.699 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OTOGLNM_001378609.3 linkc.5094T>C p.Asn1698Asn synonymous_variant Exon 44 of 59 ENST00000547103.7 NP_001365538.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OTOGLENST00000547103.7 linkc.5094T>C p.Asn1698Asn synonymous_variant Exon 44 of 59 5 NM_001378609.3 ENSP00000447211.2 Q3ZCN5
OTOGLENST00000646859.1 linkc.4959T>C p.Asn1653Asn synonymous_variant Exon 48 of 63 ENSP00000496036.1 A0A2R8YF04
OTOGLENST00000298820.7 linkc.393T>C p.Asn131Asn synonymous_variant Exon 5 of 18 5 ENSP00000298820.3 H7BXL6

Frequencies

GnomAD3 genomes
AF:
0.519
AC:
78823
AN:
151906
Hom.:
22649
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.256
Gnomad AMI
AF:
0.488
Gnomad AMR
AF:
0.479
Gnomad ASJ
AF:
0.629
Gnomad EAS
AF:
0.719
Gnomad SAS
AF:
0.596
Gnomad FIN
AF:
0.683
Gnomad MID
AF:
0.551
Gnomad NFE
AF:
0.635
Gnomad OTH
AF:
0.554
GnomAD2 exomes
AF:
0.584
AC:
139845
AN:
239328
AF XY:
0.596
show subpopulations
Gnomad AFR exome
AF:
0.246
Gnomad AMR exome
AF:
0.405
Gnomad ASJ exome
AF:
0.625
Gnomad EAS exome
AF:
0.709
Gnomad FIN exome
AF:
0.687
Gnomad NFE exome
AF:
0.637
Gnomad OTH exome
AF:
0.590
GnomAD4 exome
AF:
0.620
AC:
900538
AN:
1453564
Hom.:
283500
Cov.:
41
AF XY:
0.621
AC XY:
448778
AN XY:
722732
show subpopulations
African (AFR)
AF:
0.240
AC:
8004
AN:
33394
American (AMR)
AF:
0.415
AC:
18325
AN:
44120
Ashkenazi Jewish (ASJ)
AF:
0.620
AC:
16129
AN:
26004
East Asian (EAS)
AF:
0.726
AC:
28717
AN:
39534
South Asian (SAS)
AF:
0.608
AC:
51692
AN:
85024
European-Finnish (FIN)
AF:
0.687
AC:
36531
AN:
53204
Middle Eastern (MID)
AF:
0.529
AC:
3028
AN:
5720
European-Non Finnish (NFE)
AF:
0.634
AC:
701683
AN:
1106422
Other (OTH)
AF:
0.606
AC:
36429
AN:
60142
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
15504
31008
46511
62015
77519
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18478
36956
55434
73912
92390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.519
AC:
78837
AN:
152024
Hom.:
22649
Cov.:
32
AF XY:
0.523
AC XY:
38829
AN XY:
74308
show subpopulations
African (AFR)
AF:
0.256
AC:
10620
AN:
41494
American (AMR)
AF:
0.479
AC:
7318
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.629
AC:
2183
AN:
3472
East Asian (EAS)
AF:
0.718
AC:
3707
AN:
5162
South Asian (SAS)
AF:
0.596
AC:
2873
AN:
4824
European-Finnish (FIN)
AF:
0.683
AC:
7216
AN:
10560
Middle Eastern (MID)
AF:
0.548
AC:
160
AN:
292
European-Non Finnish (NFE)
AF:
0.635
AC:
43145
AN:
67936
Other (OTH)
AF:
0.555
AC:
1170
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1721
3443
5164
6886
8607
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
692
1384
2076
2768
3460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.588
Hom.:
81076
Bravo
AF:
0.488
Asia WGS
AF:
0.631
AC:
2192
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 09, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Nov 24, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Asn1689Asn in exon 43 of OTOGL: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue and is not located wi thin the splice consensus sequence. It has been identified in 36.2% (2963/8184) of European American chromosomes from a broad population by the NHLBI Exome Sequ encing Project (http://evs.gs.washington.edu/EVS; dbSNP rs10778727). -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.51
CADD
Benign
6.1
DANN
Benign
0.80
PhyloP100
0.26
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10778727; hg19: chr12-80735771; COSMIC: COSV54014242; COSMIC: COSV54014242; API